Shengli Xu

447 citations
12 papers · 343 indexed · h-index 10
Topics
Parkinson's Disease Mechanisms and Treatments (7 papers)Nuclear Receptors and Signaling (4 papers)Alzheimer's disease research and treatments (3 papers)
Partner nations
ChinaJapanCanada

In The Last Decade

Shengli Xu

12 papers receiving 336 citations

Peers

Shengli Xu
Comparison fields: 5 of 70
  • Neurology 194
  • Cellular and Molecular Neuroscience 117
  • Molecular Biology 95
  • Physiology 77
  • Neurology 63
Replace Hilary Grosso Jasutkar with:
Hilary Grosso Jasutkar United States
Yutaka Oji Japan
Taylor A Seaton United Kingdom
Manish Verma United States
Kanmin Mao China
Ross B. Mounsey United Kingdom
Akiyoshi Morinaga Japan
Joyshree Biswas India
Jeswinder Sian‐Hülsmann Germany
Wen-Shuo Geng China
Shengli Xu relative to Hilary Grosso Jasutkar United States Hilary Grosso Jasutkar's profile →
Citations per field
00.5×1.5×
Hilary Grosso Jasutkar · 1×
Citations per year

Countries citing papers authored by Shengli Xu

Since Specialization
Citations

This map shows the geographic impact of Shengli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengli Xu more than expected).

Fields of papers citing papers by Shengli Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengli Xu. The network helps show where Shengli Xu may publish in the future.

Co-authorship network of co-authors of Shengli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shengli Xu. A scholar is included among the top collaborators of Shengli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengli Xu. Shengli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 3
2 1
3 40
4 14
5 32
6 34
7 18
8 33
9 38
10 49
11 27
12 54

About Shengli Xu

Shengli Xu is a scholar working on Neurology, Complementary and alternative medicine and Neurology, having authored 12 papers that have together received 343 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (7 papers), Nuclear Receptors and Signaling (4 papers) and Alzheimer's disease research and treatments (3 papers). The work is most often cited by research in Neurology (194 citations), Neurology (63 citations) and Cellular and Molecular Neuroscience (117 citations). Shengli Xu has collaborated with scholars based in China, Japan and Canada. Frequent co-authors include Piu Chan, Ming Zhou, Kenji Uéda, Yanning Cai, Piu Chan, Shun Yu, Xiaohong Zuo, Alex Zhang, Ruiping Zhang and Lili Wang. Their work appears in journals such as Brain Research, Biochemical and Biophysical Research Communications and Journal of Neuroinflammation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026